DESCRIPTION
In this episode I describe my own impressions on the multibillion dollar industry that has emerged around the new-ish opioid 7-hydroxymitragynine and speak with two industry insiders, Soren Shade who works as a kratom leaf vendor and policy reformer and Dr. Ahmed Alford who has studied the chemistry and pharmacology of natural Kratom alkaloids and their synthetic derivatives and has worked with the 7-hydroxymitragynine grey market.